Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
Conditions: Methicillin-resistant Staphylococcus Aureus; Skin Infection Interventions: Drug: TMP-SMX; Drug: DOXY Sponsors: Los Angeles Biomedical Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Washington University School of Medicine; University of California, Los Angeles Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2018 Category: Research Source Type: clinical trials